CS logo
small CS logo
The Second Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China
Hospital in Suzhou
1055 Sanxiang Rd, Jin Chang Qu, Suzhou, Jiangsu, 215025

About The Second Affiliated Hospital of Soochow University


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Second Affiliated Hospital of Soochow University
14
Pfizer
5
BeiGene
4
Eli Lilly and Company
4
Ipsen
3
Janssen Research & Development, LLC
3
Jinling Hospital, China
3
Zensun Sci. & Tech. Co., Ltd.
3
Beijing Tiantan Hospital
2
Hoffmann-La Roche
2
Jiangsu HengRui Medicine Co., Ltd.
2
Total Rows: 52

Clinical Trials at The Second Affiliated Hospital of Soochow University


During the past decade, The Second Affiliated Hospital of Soochow University conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 7 clinical trials were completed, i.e. on average, 10.1% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 4 clinical trials were completed. i.e. 10.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44335510109912121414111111000011220000112211Started TrialsCompleted Trails201520162017201820192020202120222023051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension
2007-01-01
2007-11-01
Completed
1,134
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial
2008-08-01
2011-08-01
Unknown status
1,000
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
2010-04-01
2012-08-01
Terminated
331
Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy
2010-11-01
2011-07-01
Unknown status
200
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia
2010-10-01
2011-10-01
Completed
400
Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
2011-06-01
2012-06-01
Terminated
146

Rows per page:

1–91 of 91

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "The Second Affiliated Hospital of Soochow University" #1 sponsor was "Second Affiliated Hospital of Soochow University" with 14 trials, followed by "Pfizer" with 5 trials sponsored, "BeiGene" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Ipsen" with 4 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 52 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Soochow University" #1 collaborator was "Second Affiliated Hospital of Suzhou University" with 4 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "The First Hospital of Jilin University" with 3 trials as a collaborator, "Affiliated Hospital of Nantong University" with 2 trials as a collaborator and "Baotou Central Hospital" with 2 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 133 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSecond AffiliatedHospital of SoochowUniversity: 14Second AffiliatedHospital of SoochowUniversity: 14Pfizer: 5Pfizer: 5BeiGene: 4BeiGene: 4Eli Lilly and Company: 4Eli Lilly and Company: 4Ipsen: 3Ipsen: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Jinling Hospital, China: 3Jinling Hospital, China: 3Zensun Sci. & Tech. Co., Ltd.: 3Zensun Sci. & Tech. Co., Ltd.: 3Beijing Tiantan Hospital: 2Beijing Tiantan Hospital: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2

Created with Highcharts 11.1.0Top CollaboratorsSecond AffiliatedHospital of SuzhouUniversity: 4Second AffiliatedHospital of SuzhouUniversity: 4Astellas Pharma Inc: 3Astellas Pharma Inc: 3The First Hospital of JilinUniversity: 3The First Hospital of JilinUniversity: 3Affiliated Hospital ofNantong University: 2Affiliated Hospital ofNantong University: 2Baotou Central Hospital: 2Baotou Central Hospital: 2Henan ProvincialPeople's Hospital: 2Henan ProvincialPeople's Hospital: 2Linyi People's Hospital: 2Linyi People's Hospital: 2Qilu Hospital ofShandong University: 2Qilu Hospital ofShandong University: 2Second AffiliatedHospital of SoochowUniversity: 2Second AffiliatedHospital of SoochowUniversity: 2The Affiliated Hospitalof Qingdao University: 2The Affiliated Hospitalof Qingdao University: 2

Clinical Trials Conditions at The Second Affiliated Hospital of Soochow University


According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Soochow University" are "Chronic Heart Failure" (3 trials), "Parkinson Disease" (3 trials), "Transient Ischemic Attack" (3 trials), "Acute Stroke" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Soochow University" in a lesser frequency.

Clinical Trials Intervention Types at The Second Affiliated Hospital of Soochow University


Most popular intervention types in "The Second Affiliated Hospital of Soochow University" are "Drug" (71 trials), "Other" (7 trials), "Procedure" (7 trials), "Device" (6 trials) and "Biological" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "placebo" (4 trials), "Cyclophosphamide" (3 trials), "Rituximab" (3 trials) and "Tislelizumab" (3 trials). Other intervention names were less common.

Clinical Trials Genders at The Second Affiliated Hospital of Soochow University


The vast majority of trials in "The Second Affiliated Hospital of Soochow University" are 75 trials for "All" genders, 11 trials for "Male" genders and 5 trials for "Female" genders.

Clinical Trials Status at The Second Affiliated Hospital of Soochow University


Currently, there are 42 active trials in "The Second Affiliated Hospital of Soochow University". 5 are not yet recruiting, 26 are recruiting, 9 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 24 completed trials in The Second Affiliated Hospital of Soochow University, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in The Second Affiliated Hospital of Soochow University, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 10 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 39Phase 3: 39Phase 2: 22Phase 2: 22Not Applicable: 10Not Applicable: 10Phase 4: 9Phase 4: 9Phase 1: 5Phase 1: 5Early Phase 1: 4Early Phase 1: 4

Created with Highcharts 11.1.0Trials StatusRecruiting: 26Recruiting: 26Completed: 24Completed: 24Unknown status: 19Unknown status: 19Active, not recruiting: 9Active, not recruiting: 9Terminated: 6Terminated: 6Not yet recruiting: 5Not yet recruiting: 5Enrolling by invitation: 2Enrolling by invitation: 2